What are the latest products in the pipeline of the world’s leading drug companies? How are the pharmaceutical giants and key niche players performing financially – in terms of stock performance, share value, price ratios, etc.? What are the latest deals, alliances and agreements among drug developers and manufacturers? These are just some of the questions answered by the following extensive selection of in-depth pharmaceutical company profiles. Examine the market strategy, organisational structure
and product range performance of the likes of Procter & Gamble, Merck & Co, Eli Lilly, Pfizer, GlaxoSmithKline, Novartis and Bayer Schering. Numerous SWOT (Strengths, Weaknesses, Opportunities and Threats) company reports are also listed.
No results for these criteria. Please adjust the applied filters, or try a different query.